SectorBiological Technology
Established Date--
Listing Date23/03/2012
ExchangeNASDAQ Stock Exchange
Full-time Employees9
Fiscal Year Ends31/12
Security TypeCommon stock
Office address4960 Peachtree Industrial Blvd.
, Suite 240
, Norcross
, GA 30071
Business
IntroductionGalectin Therapeutics Inc., established in July 2000 as Pro Pharma, is a development-stage company engaged in drug development to create new therapies for cancer and fibrotic diseases. Glaxti's drug candidate is based on an approach targeting the galactoagglutinin protein, a key mediator of biological and pathological functions. Glaxti uses naturally occurring, readily available plant materials as raw materials to create proprietary complex carbohydrates with specific molecular weights and pharmaceutical properties during the production process.
